| NTRS |
Report |
EPS (diluted, Q2 2026) |
BEAT |
pred ~$2.72 vs. cons $2.63 |
MEDIUM |
| NTRS |
Report |
Trust & servicing fees |
BEAT |
pred ~$1.34B vs. cons ~$1.31B |
MEDIUM |
| NTRS |
Report |
Net interest income (FTE) |
IN-LINE |
pred ~$648M vs. cons ~$645M |
LOW |
| NTRS |
Guide |
FY2026 NII growth guide |
UNCHANGED |
guide ~mid-to-high single digit (~7%) vs. cons ~7% (FY2026) |
MEDIUM |
| NTRS |
Guide |
FY2026 positive operating leverage |
UNCHANGED |
guide >100bps vs. cons >100bps (FY2026) |
MEDIUM |
| NTRS |
Guide |
Capital return / payout ratio |
UNCHANGED |
guide ~100%+ payout vs. cons ~100% (FY2026) |
MEDIUM |
| NTRS |
Guide |
Visa Class B monetization / buyback use |
UNKNOWN |
guide ~$470M pretax proceeds vs. cons undecided use ~$0 incremental (2H2026) |
LOW |
| NTRS |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
MEDIUM |
| NTRS |
Return |
5-day cumulative residual |
-0.5% (FADE) |
A modest EPS/fee beat clears the number but the bar is elevated (stock +33% YTD, near record ~$191). Much of Q1's upside (transitory ~$9B deposit surge, FX/volatility-driven trading) is normalizing, so out-period estimates get trimmed even after a beat; deposit give-back and tough capital-markets comps cap forward NII/fee revisions. Initial pop fades as the durability question and full valuation reassert. |
LOW |